Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 19 open reading frame 85 (C19orf85) encodes an uncharacterized human protein currently lacking specific functional, mechanistic, or structural annotation in major biomedical databases. Sequence analysis shows it is 222 amino acids in length. C19orf85 is poorly studied: its function in normal physiology or disease is unknown, and no published data support direct targeting by drugs or therapeutic agents. Proteomic studies suggest C19orf85 expression is sensitive to cellular micronutrient status and diminishes in cells deficient in the metal transporter ZIP8 (SLC39A8), hinting at a role in micronutrient regulation, cellular metal ion homeostasis, or broader metabolic networks[4]. Bioinformatic network prediction implies C19orf85 may be co-expressed or interact with proteins involved in mitosis, cell cycle, and apoptosis—including Aurora kinases and DIABLO—but these are computational predictions without experimental confirmation[1]. It is not classified as a drug target, receptor, enzyme, transporter, or transcription factor, nor is it established as a disease gene or clinical biomarker. Nomenclature is consistent across sources: "Chromosome 19 open reading frame 85" (C19orf85) is the preferred name and abbreviation[1][4][6]. If you need highly structured or canonical information, this target currently lacks the molecular, mechanistic, disease, or pharmacological data seen with common therapeutic proteins.
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 19 open reading frame 85 (C19orf85).